Calcium entry blockade and agonist-mediated forearm vasoconstriction in hypertensive patients. Difference between nicardipine and verapamil R. PedrinelliS. TaddeiA. Salvetti Originals Pages: 1 - 5
Comparison of the calcium entry blockers nimodipine and flunarizine on human cerebral and temporal arteries: role in cerebrovascular disorders I. JansenP. Tfelt-HansenL. Edvinsson Originals Pages: 7 - 15
Nimodipine tested in a human model of cerebral ischaemia V. KraaierA. C. van HuffelenJ. M. Keppel Hesselink Originals Pages: 17 - 21
Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin Y. ChaoJ. S. ChenA. W. Alberts OriginalPaper Pages: S11 - S14
Acute effect of glipizide on glucose tolerance in obesity and diabetes mellitus (NIDDM) A. E. PontiroliM. G. PerfettiG. Pozza Originals Pages: 23 - 26
Clinical pharmacology of pravastatin, a selective inhibitor of HMG-CoA reductase H. Y. Pan OriginalPaper Pages: S15 - S18
Simvastatin reduces plasma lipid levels and improves insulin action in elderly, non-insulin dependent diabetics G. PaolissoS. SgambatoF. D'Onofrio Originals Pages: 27 - 31
Inhibition of cholesterol absorption by HMG-CoA reductase inhibitor T. A. Miettinen OriginalPaper Pages: S19 - S21
Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia L. Kłosiewicz-LatoszekW. B. Szostak Originals Pages: 33 - 41
Lovastatin and gemfibrozil in the treatment of type 2a and type 2b hyperlipoproteinemia M. J. TikkanenJ. -P. OjalaE. Helve OriginalPaper Pages: S23 - S25
Does tolerance develop to the sedative and amnesic effects of antidepressants? M. SakulsripongH. V. CurranM. Lader Originals Pages: 43 - 48
Comparison of different HMG-CoA reductase inhibitors H. H. DitschuneitK. Kuhn OriginalPaper Pages: S27 - S32
Disposition of oral quinine in acute falciparum malaria W. SupanaranondT. M. E. DavisN. J. White Originals Pages: 49 - 52
Effects of bezafibrate on hepatic cholesterol metabolism D. StåhlbergE. ReihnérB. Angelin OriginalPaper Pages: S33 - S36
Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines K. HäußermannB. BenzM. Eichelbaum Originals Pages: 53 - 59
Bezafibrate fails to directly modulate HMG-CoA reductase or LDL catabolism in human mononuclear cells E. E. StangeM. FrühholzH. Ditschuneit OriginalPaper Pages: S37 - S40
Lack of effect of omeprazole treatment on steady-state plasma levels of metoprolol T. AnderssonP. LundborgC. G. Reg»rdh Originals Pages: 61 - 65
Impact of dilevalol on haemodynamic changes during emotional stress H. RüddelW. LangewitzH. Schächinger Originals Pages: 67 - 70
Increased affinity of LDL for their receptors after acipimox treatment in hypertriglyceridemia G. FranceschiniF. BerniniC. R. Sirtori OriginalPaper Pages: S45 - S48
Clinical chronopharmacology of oral sustained-release isosorbide-5-mononitrate in healthy subjects B. LemmerB. ScheidelH. -J. Becker Originals Pages: 71 - 75
Coronary drug project: Experience with niacin K. G. BergeP. L. CannerCoronary Drug Project Research Group OriginalPaper Pages: S49 - S51
Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover B. H. JenningsK. -E. AnderssonS.Å. Johansson Originals Pages: 77 - 82
Bile acid sequestrants: Mechanisms of action on bile acid and cholesterol metabolism K. EinarssonS. EricssonB. Angelin OriginalPaper Pages: S53 - S58
A double-blind placebo controlled dose response study of noberastine on histamine induced weal and flare F. KamaliM. EmanuelM. D. Rawlins Originals Pages: 83 - 85
Mechanisms of action of plant sterols on inhibition of cholesterol absorption T. HeinemannG. -A. Kullak-UblickK. von Bergmann OriginalPaper Pages: S59 - S63
Pitfalls of pharmacokinetic dosage guidelines in renal insufficiency K. Turnheim Originals Pages: 87 - 93
Inhibition of cholesterol absorption by neomycin, benzodiazepine derivatives and ketoconazole Y. A. KesäniemiT. A. Miettinen OriginalPaper Pages: S65 - S67
Pharmacokinetics and converting enzyme inhibition after morning and evening administration of oral enalapril to healthy subjects K. WeisserJ. SchloosE. Mutschler Originals Pages: 95 - 99
The lipid research clinics coronary primary prevention trial: Design, results, and implications J. L. ProbstfieldB. M. Rifkind OriginalPaper Pages: S69 - S75
Pharmacokinetics of the anti-inflammatory drug ximoprofen in healthy subjects and in disease states I. W. TaylorT. TaylorL. F. Chasseaud Originals Pages: 101 - 106
Antiatherosclerotic effect of probucol in WHHL rabbits: Are there plasma parameters to evaluate this effect? B. FinckhA. NiendorfU. Beisiegel OriginalPaper Pages: S77 - S80
Pharmacokinetic profile and tolerability of pimobendan in patients with terminal renal insufficiency M. PrzecheraW. RothM. Haehl Originals Pages: 107 - 111
Clinical and therapeutic use of probucol A. BergM. W. BaumstarkJ. Keul OriginalPaper Pages: S81 - S84
Dimethly sulphoxide lowers ICP after closed head trauma M. KaracaU. Y. BilginJ. C. de la Torre Short Communication Pages: 113 - 114
Beclobrate: Pharmacodynamic properties and therapeutic use in hyperlipidemia C. WannerH. WielandW. H. Hörl OriginalPaper Pages: S85 - S89
Clinical pharmacokinetics of 3-day continuous infusion cisplatin and daily bolus 5-Fluorouracil J. F. BelliveauM. R. PosnerP. Calabresi Letters To The Editors Pages: 115 - 117
Clinical pharmacology of the hypocholesterolemic agent K 12.148 (lifibrol) in healthy volunteers H. HasibederH. J. StaabW. März OriginalPaper Pages: S91 - S94
Fluvoxamine-tricyclic antidepressant interaction G. BertschyS. VandelR. Volmat Letters To The Editors Pages: 119 - 120
